AVALON GLOBOCARE CORP (ALBT) Stock Income Statement
NASDAQ:ALBT - Nasdaq - US05344R3021 - Common Stock - Currency: USD
| TTM (2025-3-31) | 2024 (2024-12-31) | 2023 (2023-12-31) | 2022 (2022-12-31) | 2021 (2021-12-31) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.37M | 1.33M | 1.26M | 1.20M | 1.39M | |||
| Minority Interest Expense | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Cost Of Goods | 1.08M | 1.13M | 1.02M | 930.00K | 980.00K | |||
| Gross Profit | 285.70K | 205.50K | 238.20K | 270.00K | 410.00K | |||
| Operating Expenses | 5.50M | 4.18M | 7.42M | 7.72M | 7.86M | |||
| Research and Development | N/A | N/A | 109.60K | 570.00K | 900.00K | |||
| Selling, General, and Administrative Expenses | 5.50M | 4.17M | 7.31M | 6.98M | 6.83M | |||
| Operating Income | -5.22M | -3.97M | -7.18M | -7.44M | -7.45M | |||
| Interest Income/Expense | -2.81M | -2.91M | -9.75M | -3.02M | -260.00K | |||
| Other Income/Expense | -38.60K | -74.30K | -300.00 | -120.00K | 0.00 | |||
| Non Recurring Items | N/A | -949.80K | 228.30K | -1.35M | -1.38M | |||
| Income Before Taxes | -9.02M | -7.90M | -16.71M | -11.93M | -9.09M | |||
| Income Tax | N/A | 0.00 | 0.00 | 0.00 | 0.00 | |||
| Net Income | -8.86M | -7.90M | -16.71M | -11.93M | -9.09M | |||
| EBITDA | -5.04M | -3.79M | -6.97M | -7.11M | -7.14M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | -8.13 | -8.44 | -23.80 | -1.28 | -1.07 | |||
| Statistics | ||||||||
| Gross Profit Margin | 20.87% | 15.41% | 18.97% | 22.50% | 29.50% | |||
| Profit Margin | -647.00% | -592.73% | -1330.49% | -994.17% | -653.96% | |||
| Operating Profit Margin | -381.32% | -297.74% | -571.95% | -620.00% | -535.97% | |||
All data in USD